State leaders, mothers, and doctors gather at AHN's Alexis Joy D'Achille Center for Prenatal Mental Health to help raise the importance of screening and detection.

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of sufficient efficacy, the drug and medical device maker said on Thursday.

(Reuters) -Johnson & Johnson said on Thursday it will discontinue a late-stage study of its add-on treatment for major depressive disorder due to insufficient efficacy in the target patient population.

Several factors led to the Great Depression, one of the most severe economic crises in U.S. history. NPR interviewed economists who discussed the causes of the Great Depression.

The world economy could face a downturn similar to the Great Depression of the 1930s unless the U.S. rows back on its plans to impose steep tariffs on imports, a senior official at the International Chamber of Commerce warned.

Surprisingly, these can also be warning signs of depression — and if you're not sure whether your current funk is anything to worry about, these quiet cries for help from your body can help clue you in that something deeper is going on. There are a few lesser-known depression symptoms to look out for.

Depression may accelerate the accumulation of physical health conditions during middle and older age, highlighting the need for integrated care, new research suggests.

Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting

When teens experience self-hatred, they’re not just having a bad day. But psychiatrist Dr. Blaise Aguirre says it’s possible for parents to help their kids. Here’s how.

A new review has found evidence that music-based therapy may benefit people living with dementia, particularly by improving symptoms of depression. The work has been published in Cochrane Database of Systematic Reviews.

The use of GLP-1 receptor agonists corresponded with a lower risk for depression among older adults with type 2 diabetes compared with dipeptidyl peptidase 4 inhibitors, results of a target trial emulation study suggested.